Incidence of Hypocalcemia in Patients With Post-Menopausal Osteoporosis or Cancer Skeletal Related Events After Denosumab in Comparison to Zoledronic Acid in a Community Hospital Setting

Journal of Pharmacovigilance
doi 10.4172/2329-6887.1000176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients After Treatment With Zoledronic Acid or Denosumab: A Retrospective Cohort Study

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

FRI0561 Safety of Denosumab in Post-Menopausal Osteoporosis and in Cancer: A Systematic Review and Meta-Analysis

2017English

Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases

Journal of Managed Care Pharmacy
2011English

PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Severe Hypocalcemia Due to Denosumab in Metastatic Prostate Cancer

Case Reports in Nephrology
2014English

Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients With Bone Metastases of Solid Tumor

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2010English

Pms17 - Budget Impact of Denosumab in the Prevention of Skeletal-Related Events in Patients With Multiple Myeloma in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Osteocalcin, a Promising Marker of Osteoporosis: Evaluation in Post-Menopausal Females With Osteoporosis

International Journal of Advances in Medicine
2019English

Treatment of Elderly Breast Cancer Patients in a Community Hospital Setting

Archives of Surgery
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy